The MAGE-A3 protein can act as a tumor antigen, presented by mature DCs, which can stimulate the maturation of CD8+ cytotoxic T lymphocytes (CTLs) specific for MAGE-A3. The gene discussed is CD8A; the disease is neoplasm.